U.S. Department of Health and Human Services
Staff Search  

If you plan to apply, Register Early.

Registration is required at eRA Commons and grants.gov and can take 4 weeks.​

Kidney Bioengineering, Biotechnology, and Imaging

The Kidney Bioengineering, Biotechnology, and Imaging program supports research and development of new technologies for the diagnosis, monitoring, or treatment of renal disease.  Research includes new methods to noninvasively measure glomerular filtration rate, renal plasma flow, and urinary protein excretion.  The program advances studies on renal biopsy, tissue assessment, and imaging.  The portfolio also includes work under the Small Business Program, which encourages collaboration between academic investigators and small businesses.​​​​​​​​​​​​​​​​​​​​​​

 

 NIDDK Staff

 
Deborah Hoshizaki, Ph.D.Kidney and Urogenital Development; Kidney and Urology Regeneration and Repair; Urology CentersChris Ketchum, Ph.D.Deputy Director, KUH Basic Science; Renal PhysiologyPaul L. Kimmel, M.D.Clinical AKI; Kidney Translational Genetics; Kidney Centers; Kidney HIV/AIDS
Marva Moxey-Mims, M.D.Deputy Director, KUH Clinical Science; Pediatric Nephrology and Urology; Pediatric Centers; Kidney Small BusinessChristopher Mullins, Ph.D.Urology Cell Biology

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
10/3/2014Innovative Research in HIV in Kidney, Urology and Hematology (R01) (Summary) RFA-DK-14-020
9/2/2014(Re)Building a Kidney Coordinating Center (U01) (Summary) RFA-DK-14-009
9/2/2014(Re)Building a Kidney: Cells to Organ (UH2/UH3) (Summary) RFA-DK-14-010
7/30/2014NIDDK Central Repositories Non-renewable Sample Access (X01) (Summary) PAR-14-301
7/29/2014NIDDK Clinician Scientist Mentoring Award to Promote Workforce Diversity (K05) (Summary) RFA-DK-14-005
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.

 

 Research Resources

 
Resource NameDescription
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
Rare Kidney Stone Consortium

The Consortium facilitates cooperative exchange of information and resources among investigators, clinicians, patients, and researchers in order to improve care and outcomes for patients with rare stone diseases.  The consortium promotes ready…

Randomized Intervention for Children with Vesicoureteral Reflux

The purpose of this study is to learn whether all children with vesicoureteral reflux (VUR) should be treated with antibiotics. The study will tell us if prophylactic antibiotic treatment prevents urinary tract infections and renal scarring in…

United States Renal Data System

The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about end-stage renal disease (ESRD) in the United States. The USRDS is funded directly by the National Institute of Diabetes…

View Additional Research Resources

 

 NIDDK Active Trials in Kidney Disease

 
View related clinical trials from ClinicalTrials.gov.

 

 Related Study Sections

 
​​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.